Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Nishank Jain to Humans

This is a "connection" page, showing publications Nishank Jain has written about Humans.

 
Connection Strength
  
 
 
0.689
  
  1. Corken AL, Ong V, Kore R, Ghanta SN, Karaduta O, Pathak R, Rose S, Porter C, Jain N. Platelets, inflammation, and purinergic receptors in chronic kidney disease. Kidney Int. 2024 Sep; 106(3):392-399.
    View in: PubMed
    Score: 0.039
  2. Kore R, Jadvani D, Arthur JM, Jain N. Authors' Reply: Platelet Count, Platelet Volume and CKD. J Am Soc Nephrol. 2024 02 01; 35(2):250-251.
    View in: PubMed
    Score: 0.038
  3. Davis OM, Kore R, Moore A, Ware J, Mehta JL, Arthur JM, Lynch DR, Jain N. Platelet Count and Platelet Volume in Patients with CKD. J Am Soc Nephrol. 2023 11 01; 34(11):1772-1775.
    View in: PubMed
    Score: 0.037
  4. Jain N, Corken A, Arthur JM, Ware J, Arulprakash N, Dai J, Phadnis MA, Davis O, Rahmatallah Y, Mehta JL, Hedayati SS, Smyth S. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascul Pharmacol. 2023 02; 148:107143.
    View in: PubMed
    Score: 0.035
  5. Corken A, Ware J, Dai J, Arthur JM, Smyth S, Davis CL, Liu J, Harville TO, Phadnis MA, Mehta JL, Rahmatallah Y, Jain N. Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360. 2022 12 29; 3(12):2036-2047.
    View in: PubMed
    Score: 0.035
  6. Jain N, Martin BC, Dai J, Phadnis MA, Al-Hindi L, Shireman TI, Hedayati SS, Rasu RS, Mehta JL. Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis. Kidney360. 2022 08 25; 3(8):1374-1383.
    View in: PubMed
    Score: 0.034
  7. Jain N, McAdams M, Hedayati SS. Screening for Cardiovascular Disease in CKD: PRO. Kidney360. 2022 11 24; 3(11):1831-1835.
    View in: PubMed
    Score: 0.033
  8. Jain N, Phadnis MA, Martin BC, Mehta JL. Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis. Am J Cardiol. 2022 01 01; 162:209-211.
    View in: PubMed
    Score: 0.032
  9. Jain N, Wan F, Kothari M, Adelodun A, Ware J, Sarode R, Hedayati SS. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial. BMC Nephrol. 2019 10 29; 20(1):395.
    View in: PubMed
    Score: 0.028
  10. Jain N, Hunt SL, Cui H, Phadnis MA, Mahnken JD, Shireman TI, Dai J, Mehta JL, Rasu RS. Trends for and Clinical Factors Associated with Choice of Oral P2Y12 Inhibitors for Patients on Chronic Dialysis. Cardiovasc Drugs Ther. 2019 10; 33(5):511-521.
    View in: PubMed
    Score: 0.028
  11. Reilly RF, Jain N. Warfarin in nonvalvular atrial fibrillation-Time for a change? Semin Dial. 2019 11; 32(6):520-526.
    View in: PubMed
    Score: 0.027
  12. Jain N, Reilly RF. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2019 02 07; 14(2):278-287.
    View in: PubMed
    Score: 0.025
  13. Singh M, Raghavan D, Williams JS, Martin BC, Hudson TJ, Owen RR, Jain N. Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans. Am J Nephrol. 2018; 47(2):67-71.
    View in: PubMed
    Score: 0.025
  14. Jain N, Reilly RF. Hungry bone syndrome. Curr Opin Nephrol Hypertens. 2017 07; 26(4):250-255.
    View in: PubMed
    Score: 0.024
  15. Jain N, Carmody T, Minhajuddin AT, Toups M, Trivedi MH, Rush AJ, Hedayati SS. Prognostic Utility of a Self-Reported Depression Questionnaire versus Clinician-Based Assessment on Renal Outcomes. Am J Nephrol. 2016; 44(3):234-44.
    View in: PubMed
    Score: 0.023
  16. Jain N, Reilly RF. Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current?Knowledge and Future Directions. Semin Dial. 2016 09; 29(5):374-81.
    View in: PubMed
    Score: 0.022
  17. Jain N, Li X, Adams-Huet B, Sarode R, Toto RD, Banerjee S, Hedayati SS. Differences in Whole Blood Platelet Aggregation at Baseline and in Response to Aspirin and Aspirin Plus Clopidogrel in Patients With Versus Without Chronic Kidney Disease. Am J Cardiol. 2016 Feb 15; 117(4):656-663.
    View in: PubMed
    Score: 0.021
  18. Jain N, Reilly RF. Effects of dietary interventions on incidence and progression of CKD. Nat Rev Nephrol. 2014 Dec; 10(12):712-24.
    View in: PubMed
    Score: 0.020
  19. Jain N, Reilly RF. Are calcium-based phosphate binders ever preferable in dialysis patients? Semin Dial. 2014 May-Jun; 27(3):269-72.
    View in: PubMed
    Score: 0.019
  20. Jain N, Minhajuddin AT, Neeland IJ, Elsayed EF, Vega GL, Hedayati SS. Association of urinary sodium-to-potassium ratio with obesity in a multiethnic cohort. Am J Clin Nutr. 2014 May; 99(5):992-8.
    View in: PubMed
    Score: 0.019
  21. Jain N, Elsayed EF. Dietary phosphate: what do we know about its toxicity. J Nephrol. 2013 Sep-Oct; 26(5):856-64.
    View in: PubMed
    Score: 0.018
  22. Jain N, Trivedi MH, Rush AJ, Carmody T, Kurian B, Toto RD, Sarode R, Hedayati SS. Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST). Contemp Clin Trials. 2013 Jan; 34(1):136-44.
    View in: PubMed
    Score: 0.017
  23. Jain N, Hedayati SS, Sarode R, Banerjee S, Reilly RF. Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence? Clin J Am Soc Nephrol. 2013 Apr; 8(4):665-74.
    View in: PubMed
    Score: 0.017
  24. Jain N, Reilly RF. Risk factors: filling in the gap. Nat Rev Nephrol. 2012 Oct; 8(10):562-3.
    View in: PubMed
    Score: 0.017
  25. Jain N, Kotla S, Little BB, Weideman RA, Brilakis ES, Reilly RF, Banerjee S. Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol. 2012 May 15; 109(10):1510-3.
    View in: PubMed
    Score: 0.016
  26. Jain N, Hedayati SS. How should clinicians interpret cardiac troponin values in patients with ESRD? Semin Dial. 2011 Jul-Aug; 24(4):398-400.
    View in: PubMed
    Score: 0.016
  27. Gregg LP, Jain N, Carmody T, Minhajuddin AT, Rush AJ, Trivedi MH, Hedayati SS. Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. Am J Nephrol. 2019; 50(1):37-47.
    View in: PubMed
    Score: 0.007
  28. Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. JAMA. 2017 11 21; 318(19):1876-1890.
    View in: PubMed
    Score: 0.006
  29. Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes. J Am Heart Assoc. 2017 Jul 05; 6(7).
    View in: PubMed
    Score: 0.006
  30. Colbert G, Jain N, de Lemos JA, Hedayati SS. Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD. Clin J Am Soc Nephrol. 2015 Mar 06; 10(3):515-29.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.